The effects of adding zoledronic acid to neoadjuvant chemotherapy on tumour response: exploratory evidence for direct anti-tumour activity in breast cancer

Coleman, R.E. orcid.org/0000-0002-4275-1043, Winter, M.C., Cameron, D. et al. (11 more authors) (2010) The effects of adding zoledronic acid to neoadjuvant chemotherapy on tumour response: exploratory evidence for direct anti-tumour activity in breast cancer. British Journal of Cancer, 102 (7). pp. 1099-1105. ISSN 0007-0920

Abstract

Metadata

Authors/Creators:
  • Coleman, R.E. ORCID logo https://orcid.org/0000-0002-4275-1043
  • Winter, M.C.
  • Cameron, D.
  • Bell, R.
  • Dodwell, D.
  • Keane, M.M.
  • Gil, M.
  • Ritchie, D.
  • Passos-Coelho, J.L.
  • Wheatley, D.
  • Burkinshaw, R.
  • Marshall, S.J.
  • Thorpe, H.
  • AZURE (BIG01 04) , Investigators
Copyright, Publisher and Additional Information: © 2010 Cancer Research UK. From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/
Keywords: anti-tumour activity; breast cancer; chemotherapy; neoadjuvant; pathological response
Dates:
  • Published: 30 March 2010
  • Published (online): 16 March 2010
Institution: The University of Sheffield
Academic Units: The University of Sheffield > Faculty of Medicine, Dentistry and Health (Sheffield) > School of Medicine (Sheffield) > Division of Genomic Medicine (Sheffield) > Department of Oncology (Sheffield)
The University of Sheffield > Sheffield Teaching Hospitals
Depositing User: Symplectic Sheffield
Date Deposited: 22 Nov 2016 09:44
Last Modified: 22 Nov 2016 09:44
Published Version: http://dx.doi.org/10.1038/sj.bjc.6605604
Status: Published
Publisher: Cancer Research UK
Refereed: Yes
Identification Number: https://doi.org/10.1038/sj.bjc.6605604

Share / Export

Statistics